Sermorelin Side Effects: What to Expect in the First Weeks

In the first weeks of sermorelin treatment, a brief local reaction—pain, redness, or swelling where the dose was given—is the best-documented historical side effect. Headache, flushing, dizziness, nausea, sleepiness, and hives were reported less often. That evidence comes mainly from older Geref programs, including pediatric treatment and single-dose adult diagnostic use, so it cannot tell us the exact rate for today’s compounded adult prescriptions. [1]

The short answer

A small, short-lived injection-site reaction can happen. A reaction that is severe, persistent, spreading, or accompanied by whole-body symptoms is different: pause and follow the urgent instructions from your prescriber rather than assuming it is a normal adjustment. Because current sermorelin is generally compounded, the product source, storage instructions, and sterility matter alongside the molecule itself. [1] [3] [7]

For product-level precautions, see Yucca’s sermorelin safety information. Yucca’s sermorelin treatment page explains the clinician-guided care pathway. This guide focuses on first-weeks symptoms and what to do next.

What the evidence actually covers

Sermorelin acetate was marketed as Geref for two narrow uses: a diagnostic test of pituitary growth-hormone release and treatment of selected children with growth failure from idiopathic growth-hormone deficiency. FDA later determined that the discontinued products were not withdrawn for safety or effectiveness reasons, but the approvals themselves were withdrawn in 2009 and the products remain on the discontinued list. That regulatory history is not an approval of current adult wellness use or of a compounded formulation. [2] [4]

FDA’s 2010 medical review summarized the older safety record. In the pediatric program, temporary local pain, redness, or swelling was the most common treatment-related event, at roughly 16%. Less than 1% of participants had events such as flushing, headache, dizziness, sleepiness, hyperactivity, swallowing difficulty, or hives. The same review explicitly cautioned that the studied populations, doses, routes, and indications differed from other adult GHRH-analogue uses. [1]

A 2026 peer-reviewed narrative review also found that the modern evidence base for GH–IGF-1-axis peptides is heterogeneous. It describes injection-site reactions and reports endocrine, metabolic, fluid-retention, and musculoskeletal concerns across the broader peptide class, while emphasizing gaps between supervised clinical evidence and self-directed use. Class-level concerns should prompt individualized monitoring; they should not be converted into a made-up sermorelin frequency. [8]

A practical first-weeks symptom map

Handling a mild local reaction

First, check whether the reaction is truly local: note its borders, size, tenderness, and whether it is shrinking over the next several hours. Do not inject into skin that is already red, swollen, bruised, scarred, or otherwise damaged. General subcutaneous-injection guidance recommends changing sites from one injection to the next and keeping sites separated so skin can recover. [5]

Use only the technique and supplies your prescriber or dispensing pharmacy provided. Do not change concentration, dose, schedule, diluent, or storage conditions on your own. If every dose produces a larger reaction—or a reaction lasts longer each time—contact the care team before the next dose. A photo with a timestamp and a ruler nearby can be more useful than “it looked bad,” as long as it does not delay urgent care.

When the product matters as much as the peptide

Current U.S. sermorelin prescriptions are commonly compounded. FDA explains that compounded drugs are not FDA-approved and are not reviewed by the agency for safety, effectiveness, or quality before marketing. Poor compounding can result in contamination or the wrong strength. This does not mean every compounded prescription is unsafe; it means the exact pharmacy, lot, formulation, storage, and beyond-use date belong in the safety conversation. [3]

Sterility is especially important for an injectable. In 2021, a compounder recalled injectable sermorelin/ipamorelin lots because sterility could not be assured; FDA’s posted notice warned that a nonsterile injectable could cause serious, potentially life-threatening infection. A historical recall does not prove a problem with your vial, but it shows why current lot-specific notices and product appearance should never be ignored. [7]

What to track for your clinician

1. Dose date and time, exact prescribed amount, and injection site.
2. When symptoms started, their peak severity, and when they resolved.
3. For a local reaction: approximate diameter, warmth, tenderness, itching, drainage, and whether the border is spreading.
4. For whole-body symptoms: headache, flushing, dizziness, nausea, hives, breathing symptoms, swelling, or faintness.
5. Any new medicine, supplement, illness, alcohol use, dehydration, strenuous exercise, or sleep disruption that could confuse the pattern.
6. The pharmacy, formulation, concentration, lot number, storage history, and any visible change in the vial—without posting personal or prescription information publicly.

Questions to ask before the next dose

Ask whether the reaction fits the expected pattern for your exact formulation, whether the next dose should be held, and whether a technique or site review is needed. Also ask what clinical or laboratory monitoring is appropriate for your goals and risk factors. The answer should be individualized; the limited historical safety record does not support a universal internet checklist for every adult. [1] [8]

Do not double a missed dose or “test” a smaller amount unless the prescriber gives a plan. If the product contains more than sermorelin, side effects cannot automatically be assigned to sermorelin alone. Combination products, excipients, and product quality can change the safety question.

The bottom line

A small, short-lived local reaction is the clearest historically documented sermorelin side effect. The important skill is noticing when the pattern is no longer local or brief. Spreading redness, fever, drainage, worsening pain, widespread hives, breathing trouble, swelling, or fainting deserves prompt or emergency evaluation—not reassurance from a generic side-effect list. [1] [6] [7]

Keep the prescribing team in the loop, use the exact instructions for your product, and treat the pharmacy and lot as part of the medication’s identity. This article is general education and does not replace your prescriber’s dose, technique, storage, or emergency instructions.